SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Corvus Pharmaceuticals Officer Acquires 4,500 Shares for $50,475.215

Chief Business Officer Jeffrey Arcara acquired 4,500 common shares for $50,475.215.

CRVS

Related stories